Please assess the completion status of the following clinical trial:

Trial Title: A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Inclusion criteria as per the product label for LA SCCHN approved by India Health Authority~* Unresectable Locally Advanced Squamous Cell Carcinoma of the Head and Neck~* Patient willing and able to give written Informed Consent~* Patient capable of complying with study data collection procedures~Exclusion Criteria:~* Exclusion criteria as per the product label for LA SCCHN approved by India Health Authority

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).